| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 6 |
| 1 | EFAVIRENZ | 5 |
| 2 | LAMIVUDINE | 5 |
| 3 | LAMIVUDINE ORAL | 5 |
| 4 | LOPINAVIR AND RITONAVIR | 5 |
| 5 | RALTEGRAVIR | 5 |
| 6 | ATAZANAVIR | 3 |
| 7 | ATAZANAVIR SULFATE | 3 |
| 8 | NELFINAVIR MESYLATE | 3 |
| 9 | RITONAVIR | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 1 | RALTEGRAVIR | 5 | 0.0010 |
| 2 | LAMIVUDINE AND ZIDOVUDINE | 6 | 0.0008 |
| 3 | EFAVIRENZ | 5 | 0.0005 |
| 4 | LOPINAVIR AND RITONAVIR | 5 | 0.0004 |
| 5 | ATAZANAVIR | 3 | 0.0002 |
| 6 | LAMIVUDINE | 5 | 0.0002 |
| 7 | RITONAVIR 100 MG | 2 | 0.0001 |
| 8 | ANAKINRA | 1 | 0.0001 |
| 9 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |